Herpes simplex virus type 1 (HSV-1) mutants defective in immediate-early (IE) gene expression do not readily enter productive replication after infection of tissue culture cells. Instead, their genomes are retained in a quiescent, nonreplicating state in which the production of viral gene products cannot be detected. To investigate the block to virus replication, we used the HSV-1 triple mutant in1820K, which, under appropriate conditions, is effectively devoid of the transactivators VP16 (a virion protein), ICP0, and ICP4 (both IE proteins). Promoters for the HSV-1 IE ICP0 gene or the human cytomegalovirus (HCMV) major IE gene, cloned upstream of the Escherichia coli lacZ coding sequences, were introduced into the in1820K genome. The regulation of these promoters and of the endogenous HSV-1 IE promoters was investigated upon conversion of the virus to a quiescent state. Within 24 h of infection, the ICP0 promoter became much less sensitive to transactivation by VP16 whereas the same element, when used to transform Vero cells, retained its responsiveness. The HCMV IE promoter, which is not activated by VP16, also became less sensitive to the HCMV functional homolog of VP16. Both elements remained available for transactivation by HSV-1 IE proteins at 24 h postinfection, showing that the in1820K genome was not irreversibly inactivated. The promoters controlling the HSV-1 ICP4, ICP22, and ICP27 genes also became essentially unresponsive to transactivation by VP16. The ICP0 promoter was induced when hexamethylene bisacetamide was added to cultures at the time of infection, but the response to this agent was also lost by 24 h after infection. Therefore, promoter elements within the HSV-1 genome are actively repressed in the absence of IE gene expression, and repression is not restricted specifically to HSV-1 IE promoters.
A coordinated pattern of viral gene expression ensues after infection of permissive cells with herpes simplex virus type 1 (HSV-1). The five immediate-early (IE) genes are the first to be transcribed, and the resulting production of IE proteins is essential for the subsequent synthesis of early and late products (10, 23, 41) . Two of the IE proteins, ICP4 and ICP27, are required for virus replication, acting primarily at transcriptional and posttranscriptional levels, respectively (19, 45, 48) . The IE protein ICP0 is not essential for virus replication but strongly promotes entry into the lytic cycle by transactivating gene expression (11, 12, 37, 44, 52) . The mode of action of ICP0 is not understood in detail, although interaction with at least one cellular factor contributes to its activity (32, 33) . The IE genes are themselves activated by the virion structural protein VP16 (otherwise named Vmw65 or ␣-TIF), located in the tegument (6, 39, 40) . This protein acts through the sequence TAATGARAT (where R is a purine nucleotide), which is present in at least one copy upstream of all IE promoters and is recognized by the cellular factor Oct-1 (15, 29, 36) . VP16 in combination with another cell factor, HCF, forms a multiprotein complex with Oct-1 at TAATGARAT, thereby bringing the C-terminal activating domain of VP16 into proximity with factors involved in the initiation of transcription (31, 42, 46, 50, 53, 57) . Intriguingly, the betaherpesvirus human cytomegalovirus (HCMV) also contains a virion transactivating protein, shown by transfection experiments to be the phosphoprotein pp71, which acts through AP-1 and/or activating transcription factor (ATF) sequences rather than TAATGARAT (27, 51) .
Investigation of the importance of VP16 for viral gene expression has relied on the use of the HSV-1 mutant in1814 and its derivatives in1820 and in1820K (2, 24, 43) . Mutant in1814 has a 12-bp insertion in the VP16 coding sequences, disrupting a domain which is required for the formation of the multiprotein complex with Oct-1 and HCF (1, 18, 22) . When cells are infected with in1814, at low multiplicity of infection (MOI), fewer than 1% of potentially infectious virus particles form plaques: in the majority of virus-cell interactions, the genome is sequestered in a nonlinear, quiescent form (21) . To recover the quiescent virus, it is necessary to superinfect cells with other viruses which express ICP0 (21) . Therefore, in situations where IE proteins are produced at insufficient levels, the in1814 genome is converted to a state in which viral gene expression cannot be detected and virus replication is not reinitiated by provision of VP16, although the point at which virus production is arrested has not been determined. Elucidation of the basis for this observation is the key issue in understanding the phenotype of in1814, and hence the importance of VP16 for the virus replication cycle. In a broader context, a block to IE gene expression is thought to underlie the repression of viral gene expression which occurs during HSV-1 latency in neurons (20, 26, 49) ; therefore, in1814 provides a model to investigate the consequences of inhibition of IE transcription. Furthermore, the development of HSV-1 vectors for gene therapy is hindered by the repression that occurs when viral or cellular promoters are cloned into nonreplicating HSV-1 mutants, and a system to investigate the phenomenon will be valuable for this area of research (14, 16, 17) .
Study of the mechanism of repression at the molecular level requires a means of analyzing quiescent viral genomes, but this is difficult due to the complex phenotype of in1814. Even at low MOI, 0.1 to 1.0% of cells support lytic infection, and at high MOI, in1814 replicates in all cells of a culture as efficiently as wild-type HSV-1, presumably because adequate amounts of IE mRNAs and proteins are produced without the contribution of VP16 (2) . Once IE proteins have accumulated to levels sufficient to promote the initiation of lytic replication, activation of all classes of viral genes is very efficient (5, 8) . The presence of even a small number of lytically infected cells provides a background of gene expression which, at the experimental level, masks events in cells containing quiescent genomes. To overcome this problem, methods of reducing IE gene expression even further have been devised. Virus in1820 is in1814 with the ICP0 promoter replaced by the Moloney murine leukemia virus long terminal repeat promoter (24, 43) : in1820 is a host range mutant which is effectively devoid of ICP0 activity in all cell types tested except BHK, in which it replicates almost as efficiently as wild-type HSV-1 despite the VP16 mutation. Pretreatment with alpha interferon, which inhibits IE gene transcription, resulted in improved cell survival at a high MOI of in1820 and enabled the structure of quiescent genomes to be investigated (24) . More recently, the temperature-sensitive mutation of tsK, which renders the major transactivator protein ICP4 nonfunctional at temperatures higher than 38°C (9, 41) , was cloned into the in1820 genome to produce in1820K (43) . At 38.5°C, in1820K is effectively devoid of the three major regulators of gene expression, VP16, ICP0, and ICP4, yet it can be propagated and its titer can be determined efficiently at 31°C in BHK cells in the presence of hexamethylene bisacetamide (HMBA), an agent which complements the replication of in1814 (30, 43) . It is possible to infect cultures with 5 PFU of in1820K per cell at 38.5°C without significant cell death, and at this MOI all cells transiently express foreign gene products when the HCMV major IE promoter is placed upstream of the coding sequences (43) .
We have used in1820K as a vehicle to produce cultures in which virtually all cells contain quiescent viral genomes, and we describe here an investigation of viral gene regulation during conversion to the quiescent state.
MATERIALS AND METHODS
Cells and viruses. BHK cells were used for routine propagation of viruses, with 3 mM HMBA added for the first 24 to 48 h after infection for viruses encoding mutant VP16. HFL (Flow 2002) cells were obtained from Flow Laboratories. Vero cells transformed to G418 resistance by transfection of plasmid pMJ90, encoding the neomycin phosphotransferase (npt) gene controlled by the HSV-1 ICP0 promoter, were described by Nicholl and Preston (34) . Virus mutants derived from HSV-1 17 were described previously: in1814 was described by Ace et al. (2); in1332 was described by Preston et al. (43) , and in1321 was described by Nicholl and Preston (34) . Mutant in1331 was constructed by cotransfection of ScaI-cleaved pMJ102 (34) with in1820K DNA, selection of thymidine kinasenegative mutants, and analysis by Southern hybridization, as described previously (24) . Mutant in1335 was similarly constructed by cotransfection of ScaI-cleaved pTM8 (28) with in1820K DNA. A summary of the structures of recombinant viruses is presented in Table 1 . All titers of mutants derived from in1814 are expressed as the value on BHK cells at 31°C in the presence of 3 mM HMBA. HCMV AD169 was propagated and subjected to titer determination on HFL cells. Where present, cycloheximide and cytosine arabinoside (AraC) were added at a final concentration of 50 g/ml each. The HSV-1 mutant tsK (41) was irradiated with UV light to reduce the titer at 31°C by a factor of greater than 5 ϫ 10 5 , as described previously (35) . RNA analysis. Polyadenylated RNA was extracted and analyzed by electrophoresis, blotting, and hybridization, as described previously (34) . The probes were DNA fragments specific for HSV-1 IE genes, ␥-actin, or lacZ (2, 34) .
Assay for ␤-galactosidase. The cells were washed with ice-cold phosphatebuffered saline (PBS), scraped into PBS, and harvested by centrifugation. The pellets were suspended in 100 l of lysis buffer (5 mM Tris-HCl [pH 7.5], 2 mM MgCl 2 , 10 mM NaCl, 5 mM ␤-mercaptoethanol) per 10 6 cells. Samples of cytoplasmic extracts were incubated at 37°C in reaction mixtures containing 25 mM glycine-NaOH (pH 9.0), 125 mM NaCl, 2 mM MgCl 2 , 6 mM ␤-mercaptoethanol, and 0.1 mg of 4-methylumbelliferyl-␤-D-galactopyranoside per ml. Reactions were stopped by the addition of trichloroacetic acid to 5% (vol/vol), and after 10 min at 4°C the mixtures were centrifuged at 10,000 ϫ g for 2 min.
Samples of the supernatants were added to 1.9 ml of glycine-Na 2 CO 3 (pH 10.7), and fluorescence was measured in a TK0 100 fluorometer (Biotech Instruments Ltd., Luton, United Kingdom); the amount of supernatant added was varied to ensure that readings were measured on the linear response range of the fluorometer. Protein concentrations in extracts were determined by use of a FolinLowry-based assay kit (Sigma). ␤-Galactosidase activities were expressed as arbitrary fluorescence units, after correction for protein concentrations of cell extracts.
RESULTS

HSV-1 mutants with multiple mutations.
The aim of this study was to investigate and characterize the responses of promoters after infection of cells with in1814-based mutants, to obtain information on the mechanism of repression of gene expression. We therefore wished to study the regulation of IE and other promoters within the in1814 genome, and experiments of this nature clearly required a means of analyzing viral RNA production. It was not possible to use in1814 itself, because the subpopulation of cells which supported productive replication of in1814 produced large amounts of RNA which masked that synthesized in the cells harboring quiescent genomes. This was also the situation when mutant in1820, which is effectively negative for ICP0 expression as well as defective for VP16 activity, was used (results not shown). To prevent the production of functional IE proteins, the mutation from tsK was additionally cloned into in1820 to yield in1820K. This mutant effectively lacks functional VP16, ICP0, and ICP4 upon infection of cells at 38.5°C (43) , thereby providing a means of analyzing the intrinsic activities of promoters when cloned into the HSV-1 genome without the complication of a background of expression due to the strong activation of gene expression by IE proteins.
Mutant in1820K was modified by the insertion of the lacZ gene controlled by the HSV-1 IE ICP0 or ICP4 promoter or by the HCMV major IE promoter to produce in1331, in1335, and in1332, respectively. HFL cells were infected with these mutants at 38.5°C in the presence of cycloheximide and coinfected with HSV-1 or HCMV to provide the homologous or heterologous virion transactivator proteins. RNA was analyzed at 6 h postinfection (Fig. 1 ). The ICP4 promoter was, as expected, transactivated upon coinfection with HSV-1 (Fig. 1, lane 2) whereas HCMV gave a much smaller effect that was difficult to estimate (due to the low levels of lacZ-specific RNA produced without coinfection and with HCMV; lanes 1 and 3). The HCMV IE promoter was responsive to infection with HCMV but not HSV-1 (lanes 4 to 6), and the ICP0 promoter was activated by HSV-1 but was also responsive to HCMV (lanes 7 to 9). The experiment demonstrates that the virion transactivator proteins of HSV-1 (VP16) and HCMV (presumably pp71) can act in trans when their target sequences are cloned into the in1820K genome and that, in agreement with previous data, the HCMV IE promoter is not activated by VP16 (51). An ATF site in the ICP0 promoter (55) may explain the response to the HCMV virion protein.
HSV IE promoters lose responsiveness to VP16. HFL fibroblasts were infected with 5 PFU of in1331 per cell and maintained at 38.5°C for 24 h. Under these conditions, no cytopathic effects were observed, and the cells remained viable (43) . After the 24-h period HFL cell monolayers were treated with cycloheximide and either mock infected or infected with HSV-1 (to provide VP16). RNA was analyzed 6 h later (Fig. 2 , lanes 7 and 8). Cells were also mock infected or infected with HSV-1 in the presence of AraC for 6 h, as a control to ensure that in1331 genomes were still present and available for transcription when transactivated by IE proteins produced by the superinfecting HSV-1 (lanes 5 and 6). A duplicate set of monolayers was mock infected and maintained at 38.5°C for 24 h and then coinfected with in1331 and HSV-1 in parallel with the superinfected set. Activation of the ICP0 promoter by VP16 occurred, as expected, when the cells were coinfected with HSV-1 (lanes 3 and 4), but at 24 h after infection with in1331, the response to VP16 was greatly diminished (lanes 7 and 8). The promoter was activated when coinfection (lanes 1 and 2) or superinfection (lanes 5 and 6) was carried out without cycloheximide, demonstrating that the in1331 genome was not irreversibly lost during incubation of the cells at 38.5°C. Therefore, the response of the ICP0 promoter to VP16 was reduced by more than 20-fold during the first 24 h of infection with in1331.
The loss of responsiveness to VP16 could be due to the effects on one or more of the proteins required for the activation of IE transcription (Oct-1, HCF, or VP16 itself). To investigate these possibilities, the experiment described above was repeated in Vero cells which had been transformed to G418 resistance by transfection of a plasmid containing the npt gene controlled by the ICP0 promoter (Fig. 3) . Cells were infected with in1331 and coinfected with HSV-1 in the presence of cycloheximide, and the activation of lacZ-and nptspecific RNAs was determined (Fig. 3, lanes 1 and 2) . Expression of both RNAs was strongly increased by coinfection with HSV-1, demonstrating that the npt gene was responsive to VP16 in the transformed cells. When infection with HSV-1 plus cycloheximide was delayed for 24 h after the initial infection with in1331, however, the lacZ RNA level was reduced but the accumulation of npt-specific RNA was undiminished (lanes 5 and 6). Infection with HSV-1 in the presence of AraC instead of cycloheximide activated both genes in coinfection (lanes 3 and 4) and superinfection (lanes 7 and 8). As a control to ensure that the lacZ and npt coding sequences were repressed in an equivalent manner, untransformed Vero cells were coinfected with in1331 and in1321 and additionally coinfected with HSV-1 plus cycloheximide either immediately or at 24 h after the initial infection (Fig. 4) . Mutant in1321 is in1820 with the npt gene controlled by the ICP0 promoter, using the same plasmid to construct the virus recombinant as for the transformation of Vero cells. Coinfection with HSV-1 in the presence of cycloheximide activated the expression of both RNAs over that observed with cycloheximide alone (Fig. 4, lanes 2 and 4) , but when HSV was applied by superinfection at 24 h after the initial infection with in1331 and in1321, both lacZ-and nptspecific RNAs were produced in much smaller amounts (lanes 3 and 5).
The experiments in Fig. 3 and 4 demonstrate that the conversion of the ICP0 promoter to a state in which it is less responsive to VP16 is not a consequence of a change in the 5, and 9) , and incubated at 38.5°C for 6 h. RNA was extracted and analyzed by hybridization to actin-and lacZ-specific probes. 5) , or 5 PFU of HSV-1 per cell plus AraC (lanes 2 and 6), and RNA was extracted after incubation at 38.5°C for 6 h. The RNA blot was hybridized with probes specific for actin and lacZ. Hybridization to lacZ RNA relative to actin was calculated by phosphorimage analysis (Z/A), with the result for lane 6 given a value of 100. The asterisk indicates that quantification for lane 2 is of limited accuracy due to a background spot above the actin band. 7) . RNA was extracted after incubation at 38.5°C for 6 h. The RNA blot was hybridized with probes specific for actin, lacZ, and npt. intracellular environment such that activation by VP16 is impaired. Rather, the important factor is that the IE promoter is located in the viral genome. The results also demonstrate that repression occurs in both HFL and Vero cells and is not affected by the nature of the reporter gene introduced into the in1820K genome.
To determine whether all IE promoters are repressed in the same way as the ICP0 promoter, the method used for the experiments in Fig. 2 and 3 was used with UV-irradiated tsK (UV-tsK) as the agent to provide VP16, so that levels of the IE transcripts of in1331 could be measured without background from the superinfecting virus. Monolayers were infected with in1331 or mock infected, maintained at 38.5°C, and superinfected 24 h later with UV-tsK or coinfected with UV-tsK and in1331. Blots of RNA preparations were probed for the presence of individual IE RNA species (Fig. 5A) , or for lacZ and actin-specific transcripts (Fig. 5B) . The promoters controlling the IE genes specifying ICP4, ICP27, and ICP22 were all activated upon coinfection with UV-tsK (lanes 3 and 4) but not detectably by superinfection (lanes 7 and 8) . The effects were due to the action of VP16 on the IE promoters of in1331, since UV-tsK itself did not produce detectable amounts of any of the IE mRNAs (lane 10). As shown above (Fig. 2) , superinfection with wt HSV-1 activated the lacZ gene of in1331 (Fig. 5, lane  6) , demonstrating that the in1331 genome was retained in a potentially functional form. The IE promoters of in1331 are thus repressed in the same manner as the ICP0 promoter controlling lacZ expression.
The data in Fig. 2 to 5 also show that the ICP0 promoter is activated by treatment of cells with cycloheximide. This unexpected effect applies to the ICP0 promoter when controlling lacZ (Fig. 2, lane 3; Fig. 3, lane 2; Fig. 4, lane 4) and to the other IE promoters when controlling their normal mRNAs (Fig. 5, lanes 3) . The basis for the induction is unknown, but it is noteworthy that during the 24 h after infection of the cells, the in1331 genome became refractory to this response.
Repression is not specific for HSV-1 IE promoters. The HCMV IE promoter is active when cells are infected with in1332 in the presence of cycloheximide, and it is transactivated by an HCMV virion protein in a manner that is not TAATGARAT specific (Fig. 1) . Monolayers of HFL cells were mock infected or infected with in1332, incubated at 38.5°C for 24 h, and superinfected with HCMV in the presence of cycloheximide or with HSV-1 with AraC present (Fig. 6, lanes 5 to   8) . A parallel set of monolayers was mock infected, incubated for 24 h, and coinfected with in1332 and HCMV plus cycloheximide or with HSV-1 plus AraC (lanes 1 to 4) . The activation of the HCMV IE promoter was greatly reduced when the addition of HCMV was delayed until 24 h after the initial application of in1332 (compare lanes 3 and 4 with lanes 7 and 8), although the response to infection with HSV-1 without cycloheximide was unaltered (lanes 2 and 6). Repression of gene expression is therefore not confined specifically to HSV-1 IE promoters but also applies to the activation of the HCMV major IE promoter by the HCMV virion protein. As noted above for the ICP0 promoter, cycloheximide treatment also turned on the HCMV IE promoter, and this response was FIG. 4 . npt is repressed as effectively as lacZ. Vero cell monolayers were mock infected (lanes 1, 2, and 4) or infected with 2.5 PFU per cell of in1321 and in1331 (lanes 3 and 5) and maintained at 38.5°C for 24 h. Two mock-infected cultures were then infected with 2.5 PFU of in1321 and in1331 per cell (lanes 2 and 4). The monolayers were treated with cycloheximide (lanes 4 and 5) or 5 PFU of HSV-1 per cell plus cycloheximide (lanes 2 and 3) and incubated at 38.5°C for 6 h, and RNA was prepared. The RNA blot was hybridized with probes specific for actin, lacZ, and npt. In lane 2 and to a lesser extent in lanes 3 and 4, an npt-related transcript slightly larger than actin mRNA is present, as described previously (34) . 5) , or 5 PFU of HSV-1 plus AraC (lanes 2 and 6), and RNA was extracted after incubation at 38.5°C for 6 h. The RNA blot was hybridized with probes specific for actin and lacZ. Hybridization of lacZ RNA relative to actin was calculated by phosphorimage analysis (Z/A).
reduced at 24 h after infection with in1332 (compare lanes 3 and 7). The activation of the HCMV IE promoter by cycloheximide treatment was described previously (3); the effect is thought to be mediated by activation of NF-B, which binds to the 18-bp repeats of the promoter (47).
In the experiments described in Fig. 6 and 2, up to twofold more lacZ RNA was produced after superinfection with HSV-1 plus AraC than during coinfection with these agents (compare lanes 2 and 6). This is presumably due to the relatively slow uncoating of HSV-1 DNA in HFL cells, resulting in more genomes being available for transcription at 24 h postinfection (24) .
The ICP0 promoter loses responsiveness to HMBA. The agent HMBA activates IE gene expression from the in1814 genome, and although the basis of this effect is not known in detail, it is clear that HMBA does not act through TAATGA RAT elements, since many diverse promoters are responsive to the agent (7). We therefore investigated whether the response of the ICP0 promoter to HMBA is diminished when in1331 is retained in cells. Monolayers of HFL cells were infected with in1331, incubated at 38.5°C for 24 h, and treated with HMBA or superinfected with HSV-1 with AraC present. A parallel set of plates were mock infected, maintained at 38.5°C for 24 h, infected with in1331, and immediately treated with HMBA or coinfected with HSV-1 plus AraC. The accumulation of ␤-galactosidase in a 6-h period was determined ( Table 2 ). The stimulation of ␤-galactosidase production by HMBA was greatly reduced in cells infected with in1331 for 24 h, but addition of HSV-1 resulted in equivalent amounts of enzyme regardless of whether it was applied by coinfection or superinfection. The ICP0 promoter therefore became much less responsive to activation by HMBA.
DISCUSSION
The experiments described here demonstrate that, in the absence of functional levels of the three major transactivator proteins VP16, ICP0, and ICP4, expression from HSV-1 and HCMV IE promoters is repressed within 24 h of infection. The effect occurs in both HFL and Vero cells and is independent of the reporter gene, since both lacZ and npt are repressed when present in the viral genome. The ineffectiveness of IE promoters is not due simply to the absence of functional transcription factors but to active repression, rendering the promoters insensitive to transactivators to which they are responsive at the time of infection. Repression applies to the "natural" transactivator proteins VP16 and pp71 and also to the less well characterized actions of cycloheximide and HMBA. The effects on IE promoters underlie the quiescent state reached by in1814, in1820, and in1820K genomes upon infections of fibroblasts.
Reduced amounts of lacZ RNA were produced upon superinfection of in1331-infected cells with HSV-1 plus cycloheximide (Fig. 2, lanes 4 and 8) or upon superinfection of in1332-infected cells with HCMV plus cycloheximide (Fig. 6, lanes 4  and 8) , but in both cases lacZ-specific RNA was undetectable after treatment with cycloheximide at 24 h postinfection ( Fig.  2 and 6, lanes 7) . Therefore, fewer new lacZ-specific RNA molecules were produced in response to virion transactivators, but the results may indicate a reduction in the number of cells responsive to all stimuli tested (except infection with HSV-1) rather than an equal effect in each infected cell. Studies in which lacZ expression was analyzed by histochemical staining and counting of positive individual cells supported the view that fewer cells were responsive (41a).
To determine whether repression was specific for promoters containing TAATGARAT, it was necessary to use an alternative promoter active under IE conditions to avoid observing secondary effects due to the absence of IE proteins. This was not straightforward, since most heterologous promoters cloned into the HSV-1 genome are dependent upon IE protein synthesis for activity; i.e., they behave as early or late promoters (38) . The HCMV IE promoter is an exception, however; therefore, it was used to investigate whether repression is TAAT GARAT specific. Our results confirm that HCMV particles contain a protein that can act on the HCMV IE promoter and additionally demonstrate that the response can be obtained when the IE promoter is in a heterologous herpesvirus genome, in agreement with previous observations made with transformed cells or in transfection assays (27, 51) . We also confirm that VP16 does not activate the HCMV IE promoter even when the promoter is located in the HSV-1 genome, supporting the results of Stinski and Roehr (51) .
The finding that activation by VP16 is not affected when the ICP0 promoter is resident in the cell genome demonstrates that the activities of Oct-1 and HCF are not significantly affected by infection with in1820K. Furthermore, the presence or induction of factors which prevent specific activation at TA ATGARAT is unlikely. The existence of the promoter within the viral genome appears to be a major parameter determining whether repression occurs, suggesting that the gross structure of the quiescent genome influences IE promoter regulation. During retention of in1820 in HFL cells, a regular distribution of nucleosomes was not detected on the HSV-1 thymidine kinase (TK) gene, whereas the same sequences adopted a regular chromatin structure when integrated into the cell genome (24) . This observation correlates with the functional behaviour of the npt gene, described here, which is repressed when incorporated into the HSV genome but not when used to transform cells. Further studies on the structure of quiescent HSV DNA may therefore clarify the relationship between repression and assembly into a regular chromatin structure.
Intriguingly, inhibition of transcription from the ICP0 promoter after treatment of cells with alpha interferon also occurs when the element is in the viral genome but not when it is resident in cells (34) , suggesting that repression of gene expression and inhibition of IE transcription by alpha interferon may act through some common factors. It should be noted, however, that induction of interferon is not implicated in the repression observed here, for two reasons: first, Vero cells lack the type 1 interferon genes, although they retain the response pathway to the cytokine (54) , and, second, pretreatment of HFL cells with growth medium from cultures infected with in1321 did not itself mediate repression (41a). At present, we have two hypotheses to explain repression of gene expression. In the first of these, in the absence of viral IE proteins to force transcription and entry into lytic replication, the viral genome is converted to an inactive state possibly similar to heterochromatin, in which the promoters are shielded from transactivating proteins. Assembly of chromatin and activation by transcription factors can be mutually exclusive (13); one particularly relevant example is the pseudorabies virus major IE protein, the homolog of HSV-1 ICP4 (58) . The second possibility is that repression acts through specific sequences other than TAATGARAT but which are common to HSV IE promoters and the HCMV IE promoter. Early studies identified only TAATGARAT and the TATA box as common to all HSV IE upstream regions (29, 56) , and TAATGARAT is not present in the HCMV IE promoter (4). Nonetheless, it remains possible that binding sites exist for factors which recognize degenerate motifs and that these sites escaped the initial analyses. In both hypotheses, cellular factors are crucial for the repression of IE gene expression, and thus alterations to cell metabolism could affect the balance between replication and retention of the viral genome. The system that we describe here provides a basis for distinguishing between the possible models for repression of HSV-1 gene expression in tissue culture cell.
Repression is the normal outcome of infection when IE transcription is blocked; therefore, our findings are relevant to models for the establishment and maintenance of latency, which in many ways is similar to the quiescent state attained by VP16-impaired viruses in culture. In addition, the results are important for the development of HSV-1 vectors, since removal of IE gene functions is crucial for the production of mutants which fail to kill cells and hence can be considered useful starting points (25, 43, 59) .
